ForbesDennisonPorterMD

Clinical Trials

• Study of Smith-Lemli-Opitz Syndrome Start of enrollment: 1998 Sep 13

  Completed

• Study of Inborn Errors of Cholesterol Synthesis and Related Disorders Start of enrollment: 2002 Oct 09

  Recruiting

• Simvastatin Therapy in Smith-Lemli-Opitz Syndrome Start of enrollment: 2003 Jul 01

  Completed

  Phase 2

• Evaluation of Biochemical Markers and Clinical Investigation of Niemann-Pick Disease, Type C Start of enrollment: 2006 Aug 14

  Recruiting

• Streptococcal Infection and Respiratory Distress in Newborns Start of enrollment: 2008 Feb 04

  Completed

• Cholesterol in ASD: Characterization and Treatment Start of enrollment: 2009 Jul 28

  Completed

  Phase 1, Phase 2

• Biomarker Validation for Niemann-Pick Disease, Type C: Safety and Efficacy of N-Acetyl Cysteine Start of enrollment: 2009 Aug 01

  Completed

  Phase 1, Phase 2

• Exome Sequencing in Autistic Spectrum Disorder Start of enrollment: 2010 Jan 21

  Completed

• Sterol and Isoprenoid Disease Research Consortium: Smith-Lemli-Opitz Syndrome Start of enrollment: 2011 Jan 01

  Terminated

  Not Applicable

• Next Generation to Identify Genetic Causes of Disease in Patients Participating in NICHD Clinical Protocols Start of enrollment: 2011 Jun 16

  Completed

• A Long-Term Study of Cholesterol Supplements for Smith-Lemli-Opitz Syndrome Start of enrollment: 2011 Jun 29

  Withdrawn

• Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 Disease Start of enrollment: 2013 Jan 01

  Completed

  Phase 1

• Phase 1/2 Study of Vorinostat Therapy in Niemann-Pick Disease, Type C1 Start of enrollment: 2014 Apr 25

  Completed

  Phase 1, Phase 2

• Establishment of Genomic and Phenotypic Database for Niemann-Pick Disease, Type C Start of enrollment: 2022 Nov 28

  Recruiting

  Roles: Principal Investigator, Contact

• Join now to see all